Traditional Early Screening Looks for “Shape”, Onco-D-clare Identifies the “Source” — Which Do You Need?

When we talk about early cancer detection, most people think of imaging tests or tumor markers.
These tools are valuable for identifying structural abnormalities or elevated markers — in other words, when a disease has already begun to manifest.

But what if you could go one step earlier?
Before anything is visible or measurable, is there a way to understand your underlying genetic risk?

What is Onco-D-clare?

Onco-D-clare is a genetic risk assessment developed by RGCC, a European-based laboratory specializing in cancer diagnostics.
Unlike traditional screening, which focuses on finding existing tumors or abnormalities,
Onco-D-clare analyzes your DNA from a simple blood draw to detect specific gene variations associated with cancer development.

Traditional Screening vs. Onco-D-clare

Feature Traditional Screening Onco-D-clare
Focus Detects existing tumors or abnormalities Identifies genetic predispositions to cancer
Best for When symptoms or family history arise For proactive prevention and long-term planning
Method Imaging, biopsies, or tumor markers Single blood test; non-invasive
Application Diagnostic confirmation or early-stage detection Preventive strategy & personalized care

Who Should Consider Onco-D-clare?

  • Individuals with a family history of cancer
  • Health-conscious individuals looking to be proactive
  • People wanting to personalize their wellness or nutrition plans
  • Anyone with past environmental or toxin exposure

How We Use Onco-D-clare at BMS

At BMS, we go beyond the report.
We integrate Onco-D-clare findings with your health background, environmental exposure, nutritional status, and lifestyle to design a personalized prevention strategy, which may include:

  • Targeted nutrient support (e.g., vitamin D, selenium, folate)
  • Gut and detox system optimization
  • Heavy metal assessment and chelation recommendations
  • Lifestyle and stress management guidance

Start Protecting Your Health Before Disease Takes Shape

Early detection matters — but earlier still is risk identification.
Understanding your genetic blueprint allows you to take action before disease even has a chance to develop.

Onco-D-clare is more than a test —
It’s a foundation for personalized prevention, a roadmap to informed health decisions, and a step toward long-term vitality.

Medical Disclaimer:
The information provided in this article is for educational and reference purposes only and does not constitute medical advice or be used as a substitute for professional medical diagnosis, treatment, or advice. ALWAYS CONSULT ANY QUESTIONS YOU MAY HAVE ABOUT YOUR MEDICAL CONDITION OR MEDICAL PROBLEM THAT YOU HAVE ALWAYS CONSULT YOUR PHYSICIAN OR OTHER QUALIFIED HEALTH PROFESSIONAL. The content of this article is not intended to recommend any specific test, treatment, or medication and should not be construed as such. If you develop symptoms or require medical assistance, please contact a healthcare professional promptly.

Want to know more about RGCC cancer early screening?

Contact us now!

Whatsapp us!

Call us!
Tel: 2370 3001

Fill in your information and we will contact you!